Alpha Ketoglutarate (AKG), a Geroprotector, After Coronary Artery Bypass Grafting Surgery
CABG
Enrolment: 250 · Results not recorded
Loading the evidence…
Nutraceutical
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
CABG
Enrolment: 250 · Results not recorded
Aging
Enrolment: 120 · Results not recorded
Eye Diseases
Enrolment: 17 · Results not recorded
Adult Gliomas, Mixed
Enrolment: 13 · Results not recorded
Propionic Acidemia
Enrolment: 3 · Results not recorded
Hypertension
Enrolment: 30 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Inhalation of aerosolised liquid ammonia producing acute lung injury
Alpha-ketoglutarate inhalation lowered bronchoalveolar lavage total cell count, total protein, lactate dehydrogenase, superoxide dismutase and malondialdehyde, and increased catalase and glutathione, with corresponding improvement in lung histopathology.
Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.